ABVC Stock Summary and Trading Ideas (Abvc Biopharma | NASDAQ:ABVC)

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Abvc Biopharma trades on the NASDAQ stock market under the symbol ABVC.

As of November 9, 2026, ABVC stock price climbed to $1.02 with 26,918 million shares trading.

ABVC has a beta of 1.75, meaning it tends to be more sensitive to market movements. ABVC has a correlation of 0.08 to the broad based SPY ETF.

ABVC has a market cap of $27.23 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ABVC traded as high as $5.48 and as low as $.40.

The top ETF exchange traded funds that ABVC belongs to (by Net Assets): VTI, VXF.

ABVC has underperformed the market in the last year with a price return of -64.1% while the SPY ETF gained +13.4%. However, in the short term, ABVC had mixed performance relative to the market. It has outperformed in the last 3 months, returning 0.0% vs -1.8% return in SPY. But in the last 2 weeks, ABVC shares have been beat by the market, returning -1.9% compared to an SPY return of -1.0%.

ABVC support price is $.92 and resistance is $1.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABVC shares will trade within this expected range on the day.